The deal – terms of which were not disclosed – also provides Holland-headquartered distributor IMCD with a laboratory at which customers can conduct formulation development and testing.
Capitol’s core customer based is in Australia and New Zealand, which is where it will continue to focus after it is merged with the firm’s personal care unit and established as a separate division of IMCD ANZ.
The takeover comes just a few months after IMCD bought Indian pharmaceutical excipients production and distribution company, Indchem.
And, just a few months prior to that the firm bought the pharmaceutical ingredients business of Malaysian ingredient and excipient distributor Maxwell Pharma. It also follows a little over a year after the Netherlands firm bought Italian fine chemicals supplier Organotec .
These deals, coupled with the acquisition of South Africa’s Ethnichem in summer 2011 and the Indchem takeover, underline IMCD’s desire to establish a bigger presence in the pharmaceutical industry.